| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.6 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.028 | 0.6 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |